No abstract available
MeSH terms
-
Aged
-
Drug Monitoring / methods
-
Drug Monitoring / standards
-
Electrocardiography / methods*
-
Electrocardiography / standards
-
Female
-
Fibrinolytic Agents / pharmacology
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Male
-
Middle Aged
-
Myocardial Infarction / diagnosis*
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / mortality
-
Patient Selection
-
Point-of-Care Systems
-
Predictive Value of Tests
-
Prognosis
-
Proportional Hazards Models
-
Prospective Studies
-
Recombinant Proteins / pharmacology
-
Recombinant Proteins / therapeutic use
-
Risk Factors
-
Streptokinase / pharmacology
-
Streptokinase / therapeutic use
-
Survival Analysis
-
Time Factors
-
Tissue Plasminogen Activator / pharmacology
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
Substances
-
Fibrinolytic Agents
-
Recombinant Proteins
-
reteplase
-
Streptokinase
-
Tissue Plasminogen Activator